We assessed PAX6 expression of tumor tissues from 98 glioma patients across pathological grades 1–4 and 11 brain tissue samples (gray matter tissues of the brain containing glial cells) by tissue microarray technology. Here, PAX6 is linked to central nervous system cancer.